Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $6.36 million. The enterprise value is $3.53 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, before market open.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
INDP has 572,658 shares outstanding. The number of shares has increased by 28.05% in one year.
Current Share Class | 572,658 |
Shares Outstanding | 572,658 |
Shares Change (YoY) | +28.05% |
Shares Change (QoQ) | +29.08% |
Owned by Insiders (%) | 1,032.32% |
Owned by Institutions (%) | 120.01% |
Float | 8.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.63 |
P/TBV Ratio | 2.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.02.
Current Ratio | 1.90 |
Quick Ratio | 1.49 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -259.00% and return on invested capital (ROIC) is -161.59%.
Return on Equity (ROE) | -259.00% |
Return on Assets (ROA) | -122.21% |
Return on Invested Capital (ROIC) | -161.59% |
Return on Capital Employed (ROCE) | -571.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.25M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
INDP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.05% |
Shareholder Yield | -28.05% |
Earnings Yield | -213.92% |
FCF Yield | -182.49% |
Analyst Forecast
The average price target for INDP is $8.50, which is -23.49% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $8.50 |
Price Target Difference | -23.49% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |